WHO and the United Nations Environment Programme (UNEP) issued a major update to their assessment of endocrine-disrupting chemicals on November 17, 2026. WHO says exposure can begin before birth and reports stronger evidence of links between exposure and several areas of human health. The assessment updates the organizations’ 2012 review of chemicals that can interfere with hormone systems.
What WHO says about exposure and health
WHO says endocrine-disrupting chemicals have been detected in blood, breast milk and umbilical cord blood. Its summary describes stronger evidence of links with fertility and reproductive development, brain development and neurological function, thyroid and other hormone regulation, metabolism, immunity, and cardiovascular health. It also flags metabolic liver disease and possible kidney effects as newer areas of concern, with scientific gaps remaining. WHO’s announcement describes associations; the listed health areas are not claims that every chemical causes every outcome.
The assessment also names plastics, pesticides and personal-care products as areas of use, and bisphenol A, phthalates and polychlorinated biphenyls (PCBs) as examples of endocrine-disrupting chemicals. These examples span different substances and uses; the report’s summary does not reduce them to a single chemical class.
A detection indicates exposure; a reported health link is an association, not an individual diagnosis.
Why mixtures complicate chemical assessment
WHO says people and wildlife are exposed to mixtures, while many regulatory systems assess chemicals one at a time. That difference matters because a single-substance assessment and exposure to combinations describe different conditions.
WHO also says more than 350,000 chemicals and mixtures are registered for production and use worldwide, while only a small fraction has been evaluated for endocrine-disrupting properties. The figure counts registered chemicals and mixtures, not confirmed endocrine disruptors.
What UNEP’s companion synthesis covers
Alongside the scientific assessment, UNEP issued From Evidence to Action: Addressing Endocrine-Disrupting Chemicals Across Sectors. Its repository summary describes policy options for governments, industry and other stakeholders, with a focus on managing these chemicals across product lifecycles and promoting innovation, transparency and sustainability. The UNEP repository lists November 16, 2026, as the issue date for both documents.